Tulsi (Expanded) for Antimicrobial Properties

Research suggests that Tulsi (Ocimum tenuiflorum/sanctum) demonstrates broad-spectrum antimicrobial activity across a range of bacterial and fungal pathogens, with the available evidence drawing primarily from in vitro studies, essential oil analyses, and narrative and systematic reviews rather than clinical trials in human populations. Studies indicate measurable inhibitory effects against clinically relevant organisms including methicillin-resistant Staphylococcus aureus, multidrug-resistant Aeromonas species, Candida albicans, Streptococcus mutans, and several periodontal pathogens, with bioactive compounds such as eugenol, camphor, eucalyptol, and rosmarinic acid identified as likely contributors to these effects. Some research has also explored synergistic activity between Tulsi extracts and conventional antibiotics, as well as novel delivery applications such as silver nanoparticles and oral rinse formulations, though these remain largely preliminary and laboratory-based. The overall body of evidence is consistently supportive in direction, but the predominance of in vitro methodologies and the relative scarcity of controlled human trials mean that how reliably these findings translate to clinical outcomes in living systems remains an open question that researchers have explicitly flagged as needing further investigation.